PMS57 ASSOCIATION OF CLINICAL REMISSION AND NORMALIZED PATIENT REPORTED OUTCOMES- A VALIDATION OF TREAT-TO-TARGET FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS USING POOLED DATA FROM 3 PHASE III GOLIMUMAB CLINICAL TRIALS
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.741
https://www.valueinhealthjournal.com/article/S1098-3015(11)00880-1/fulltext
Section Title :
Disease-Specific Studies
Section Order :
205
First Page :
A133
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00880-1&doi=10.1016/j.jval.2011.02.741